COMPOSITION COMPRISING AN ENCAPSULATED ANTAGOMIR
The invention relates to a composition comprising an effective amount of at least one inhibitor of a miRNA involved in the angiogenesis, or a precursor thereof, wherein said inhibitor is microencapsulated into polymeric biodegradable and biocompatible microspheres. The invention also relates to the...
Gespeichert in:
| Hauptverfasser: | , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng ; spa |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | AMADEO PEREZ NEUS BELLERA GOTARDA ANTONIO DAVID GARCIA-DORADO GARCIA ANTONIO RODRIGUEZ SINOVAS IGNASI BARBA VERT MIGUEL-ANGEL ASIN EULALIA FERRET |
| description | The invention relates to a composition comprising an effective amount of at least one inhibitor of a miRNA involved in the angiogenesis, or a precursor thereof, wherein said inhibitor is microencapsulated into polymeric biodegradable and biocompatible microspheres. The invention also relates to the use of the said composition for preventing or treating cardiac disorders, including cardiac disorders caused by ischemy.
La presente invención se relaciona con una composición que comprende una cantidad efectiva de por lo menos un inhibidor de un ARNmi involucrado en la angiogénesis, o un precursor del mismo, en donde el inhibidor se microencapsula en microesferas poliméricas biodegradables y biocompatibles. La invención también se relaciona con el uso de tal composición para prevenir o tratar trastornos cardiacos, que incluyen trastornos cardiacos causados por isquemia. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_MX2015009323A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>MX2015009323A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_MX2015009323A3</originalsourceid><addsrcrecordid>eNrjZDBw9vcN8A_2DPH091MAsYM8gz393BUc_RRc_ZwdA4JDfRxDXF2A_BBHd39fzyAeBta0xJziVF4ozc2g5OYa4uyhm1qQH59aXJCYnJqXWhLvG2FkYGhqYGBpbGTsaEyUIgCemScM</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>COMPOSITION COMPRISING AN ENCAPSULATED ANTAGOMIR</title><source>esp@cenet</source><creator>AMADEO PEREZ ; NEUS BELLERA GOTARDA ; ANTONIO DAVID GARCIA-DORADO GARCIA ; ANTONIO RODRIGUEZ SINOVAS ; IGNASI BARBA VERT ; MIGUEL-ANGEL ASIN ; EULALIA FERRET</creator><creatorcontrib>AMADEO PEREZ ; NEUS BELLERA GOTARDA ; ANTONIO DAVID GARCIA-DORADO GARCIA ; ANTONIO RODRIGUEZ SINOVAS ; IGNASI BARBA VERT ; MIGUEL-ANGEL ASIN ; EULALIA FERRET</creatorcontrib><description>The invention relates to a composition comprising an effective amount of at least one inhibitor of a miRNA involved in the angiogenesis, or a precursor thereof, wherein said inhibitor is microencapsulated into polymeric biodegradable and biocompatible microspheres. The invention also relates to the use of the said composition for preventing or treating cardiac disorders, including cardiac disorders caused by ischemy.
La presente invención se relaciona con una composición que comprende una cantidad efectiva de por lo menos un inhibidor de un ARNmi involucrado en la angiogénesis, o un precursor del mismo, en donde el inhibidor se microencapsula en microesferas poliméricas biodegradables y biocompatibles. La invención también se relaciona con el uso de tal composición para prevenir o tratar trastornos cardiacos, que incluyen trastornos cardiacos causados por isquemia.</description><language>eng ; spa</language><subject>BEER ; BIOCHEMISTRY ; CHEMISTRY ; COMPOSITIONS THEREOF ; CULTURE MEDIA ; ENZYMOLOGY ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; MICROBIOLOGY ; MICROORGANISMS OR ENZYMES ; MUTATION OR GENETIC ENGINEERING ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS ; SPIRITS ; VINEGAR ; WINE</subject><creationdate>2016</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20160404&DB=EPODOC&CC=MX&NR=2015009323A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76290</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20160404&DB=EPODOC&CC=MX&NR=2015009323A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>AMADEO PEREZ</creatorcontrib><creatorcontrib>NEUS BELLERA GOTARDA</creatorcontrib><creatorcontrib>ANTONIO DAVID GARCIA-DORADO GARCIA</creatorcontrib><creatorcontrib>ANTONIO RODRIGUEZ SINOVAS</creatorcontrib><creatorcontrib>IGNASI BARBA VERT</creatorcontrib><creatorcontrib>MIGUEL-ANGEL ASIN</creatorcontrib><creatorcontrib>EULALIA FERRET</creatorcontrib><title>COMPOSITION COMPRISING AN ENCAPSULATED ANTAGOMIR</title><description>The invention relates to a composition comprising an effective amount of at least one inhibitor of a miRNA involved in the angiogenesis, or a precursor thereof, wherein said inhibitor is microencapsulated into polymeric biodegradable and biocompatible microspheres. The invention also relates to the use of the said composition for preventing or treating cardiac disorders, including cardiac disorders caused by ischemy.
La presente invención se relaciona con una composición que comprende una cantidad efectiva de por lo menos un inhibidor de un ARNmi involucrado en la angiogénesis, o un precursor del mismo, en donde el inhibidor se microencapsula en microesferas poliméricas biodegradables y biocompatibles. La invención también se relaciona con el uso de tal composición para prevenir o tratar trastornos cardiacos, que incluyen trastornos cardiacos causados por isquemia.</description><subject>BEER</subject><subject>BIOCHEMISTRY</subject><subject>CHEMISTRY</subject><subject>COMPOSITIONS THEREOF</subject><subject>CULTURE MEDIA</subject><subject>ENZYMOLOGY</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>MICROBIOLOGY</subject><subject>MICROORGANISMS OR ENZYMES</subject><subject>MUTATION OR GENETIC ENGINEERING</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS</subject><subject>SPIRITS</subject><subject>VINEGAR</subject><subject>WINE</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2016</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZDBw9vcN8A_2DPH091MAsYM8gz393BUc_RRc_ZwdA4JDfRxDXF2A_BBHd39fzyAeBta0xJziVF4ozc2g5OYa4uyhm1qQH59aXJCYnJqXWhLvG2FkYGhqYGBpbGTsaEyUIgCemScM</recordid><startdate>20160404</startdate><enddate>20160404</enddate><creator>AMADEO PEREZ</creator><creator>NEUS BELLERA GOTARDA</creator><creator>ANTONIO DAVID GARCIA-DORADO GARCIA</creator><creator>ANTONIO RODRIGUEZ SINOVAS</creator><creator>IGNASI BARBA VERT</creator><creator>MIGUEL-ANGEL ASIN</creator><creator>EULALIA FERRET</creator><scope>EVB</scope></search><sort><creationdate>20160404</creationdate><title>COMPOSITION COMPRISING AN ENCAPSULATED ANTAGOMIR</title><author>AMADEO PEREZ ; NEUS BELLERA GOTARDA ; ANTONIO DAVID GARCIA-DORADO GARCIA ; ANTONIO RODRIGUEZ SINOVAS ; IGNASI BARBA VERT ; MIGUEL-ANGEL ASIN ; EULALIA FERRET</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_MX2015009323A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; spa</language><creationdate>2016</creationdate><topic>BEER</topic><topic>BIOCHEMISTRY</topic><topic>CHEMISTRY</topic><topic>COMPOSITIONS THEREOF</topic><topic>CULTURE MEDIA</topic><topic>ENZYMOLOGY</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>MICROBIOLOGY</topic><topic>MICROORGANISMS OR ENZYMES</topic><topic>MUTATION OR GENETIC ENGINEERING</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS</topic><topic>SPIRITS</topic><topic>VINEGAR</topic><topic>WINE</topic><toplevel>online_resources</toplevel><creatorcontrib>AMADEO PEREZ</creatorcontrib><creatorcontrib>NEUS BELLERA GOTARDA</creatorcontrib><creatorcontrib>ANTONIO DAVID GARCIA-DORADO GARCIA</creatorcontrib><creatorcontrib>ANTONIO RODRIGUEZ SINOVAS</creatorcontrib><creatorcontrib>IGNASI BARBA VERT</creatorcontrib><creatorcontrib>MIGUEL-ANGEL ASIN</creatorcontrib><creatorcontrib>EULALIA FERRET</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>AMADEO PEREZ</au><au>NEUS BELLERA GOTARDA</au><au>ANTONIO DAVID GARCIA-DORADO GARCIA</au><au>ANTONIO RODRIGUEZ SINOVAS</au><au>IGNASI BARBA VERT</au><au>MIGUEL-ANGEL ASIN</au><au>EULALIA FERRET</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>COMPOSITION COMPRISING AN ENCAPSULATED ANTAGOMIR</title><date>2016-04-04</date><risdate>2016</risdate><abstract>The invention relates to a composition comprising an effective amount of at least one inhibitor of a miRNA involved in the angiogenesis, or a precursor thereof, wherein said inhibitor is microencapsulated into polymeric biodegradable and biocompatible microspheres. The invention also relates to the use of the said composition for preventing or treating cardiac disorders, including cardiac disorders caused by ischemy.
La presente invención se relaciona con una composición que comprende una cantidad efectiva de por lo menos un inhibidor de un ARNmi involucrado en la angiogénesis, o un precursor del mismo, en donde el inhibidor se microencapsula en microesferas poliméricas biodegradables y biocompatibles. La invención también se relaciona con el uso de tal composición para prevenir o tratar trastornos cardiacos, que incluyen trastornos cardiacos causados por isquemia.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng ; spa |
| recordid | cdi_epo_espacenet_MX2015009323A |
| source | esp@cenet |
| subjects | BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS THEREOF CULTURE MEDIA ENZYMOLOGY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY MICROBIOLOGY MICROORGANISMS OR ENZYMES MUTATION OR GENETIC ENGINEERING PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS SPIRITS VINEGAR WINE |
| title | COMPOSITION COMPRISING AN ENCAPSULATED ANTAGOMIR |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-31T10%3A12%3A24IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=AMADEO%20PEREZ&rft.date=2016-04-04&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EMX2015009323A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |